Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a... by Uhrenholt, L, Christensen, R, Dinesen, WKH, Liboriussen, CH, Andersen, SS, Dreyer, L, Schlemmer, A, Hauge, E-M, Skrubbeltrang, C, Taylor, PC, Kristensen, S